# A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease

> **NCT03436953** · PHASE2 · WITHDRAWN · sponsor: **Jazz Pharmaceuticals**

## Conditions studied

- Parkinson's Disease
- Tremor

## Interventions

- **DRUG:** CX-8998
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03436953
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-12
- **Primary completion:** 2020-09
- **Final completion:** 2020-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The program was not initiated nor were any patients ever enrolled. The investigations detailed in the submitted protocol were incorporated into another program.
- **Last updated:** 2021-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03436953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03436953, "A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03436953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*